Table 1.
Sample size, means, and standard deviations for the DSM−3R substance use symptom counts and MPQ personality measures.
| Sex | Cohort | Age | DSM-3R Dependence/Abuse Symptom Counts | Multidimensional Personality Questionnaire | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| |||||||||||||||||||||||
| Superfactor | Subfactors | ||||||||||||||||||||||
|
| |||||||||||||||||||||||
| Nicotine | Alcohol | Marijuana | Constraint | Traditionalism | Harm Avoidance | Control | |||||||||||||||||
|
| |||||||||||||||||||||||
| N | M | SD | N | M | SD | N | M | SD | N | M | SD | N | M | SD | N | M | SD | N | M | SD | |||
| Male | 1 | 17.5 | 578 | .7 | (1.6) | 578 | .6 | (1.4) | 578 | .3 | (1.2) | 501 | 129.7 | (15.3) | 503 | 51.0 | (7.2) | 505 | 42.5 | (9.7) | 507 | 46.4 | (7.1) |
| 24.3 | 525 | 1.3 | (1.9) | 525 | 1.5 | (1.8) | 524 | .5 | (1.4) | 431 | 135.7 | (15.6) | 432 | 52.9 | (7.5) | 434 | 44.6 | (10.7) | 433 | 48.9 | (7.5) | ||
| 29.7 | 532 | 1.2 | (1.8) | 532 | 1.0 | (1.5) | 530 | .4 | (1.2) | 511 | 139.4 | (15.0) | 513 | 53.3 | (6.6) | 517 | 47.3 | (10.3) | 517 | 50.4 | (7.3) | ||
| 2 | 18.0 | 661 | 1.2 | (1.9) | 663 | .9 | (1.7) | 664 | .8 | (1.9) | 635 | 130.6 | (14.8) | 638 | 51.2 | (6.7) | 643 | 42.7 | (9.4) | 642 | 47.1 | (7.0) | |
| 25.3 | 640 | 1.3 | (1.8) | 639 | 1.3 | (1.7) | 640 | .5 | (1.30) | 581 | 134.6 | (15.3) | 587 | 51.3 | (7.5) | 595 | 43.8 | (10.1) | 595 | 49.6 | (7.4) | ||
| 29.3 | 425 | 1.4 | (1.9) | 425 | .8 | (1.5) | 425 | .8 | (1.3) | 428 | 138.3 | (15.2) | 429 | 52.1 | (7.3) | 432 | 45.5 | (10.5) | 431 | 51.3 | (7.8) | ||
| Female | 1 | 17.5 | 674 | .7 | (1.7) | 674 | .4 | (1.3) | 674 | .2 | (.9) | 614 | 137.1 | (16.1) | 616 | 52.3 | (7.1) | 622 | 49.0 | (10.3) | 620 | 47.5 | (7.7) |
| 25.0 | 633 | 1.0 | (1.6) | 634 | .5 | (1.2) | 634 | .2 | (.9) | 590 | 146.2 | (14.1) | 592 | 53.0 | (6.9) | 597 | 54.7 | (9.4) | 596 | 52.4 | (7.3) | ||
| 29.6 | 636 | .8 | (1.6) | 636 | .3 | (1.0) | 635 | .1 | (.5) | 609 | 149.0 | (14.8) | 614 | 53.1 | (7.2) | 619 | 56.9 | (9.4) | 621 | 53.6 | (7.5) | ||
| 2 | 18.3 | 692 | .8 | (1.6) | 692 | .3 | (.9) | 692 | .2 | (.9) | 684 | 139.2 | (15.3) | 692 | 52.5 | (6.6) | 699 | 50.7 | (9.8) | 697 | 48.7 | (7.7) | |
| 25.2 | 579 | .9 | (1.6) | 578 | .6 | (1.3) | 576 | .2 | (.7) | 637 | 144.4 | (14.7) | 642 | 51.8 | (6.6) | 652 | 53.5 | (9.8) | 653 | 52.1 | (7.7) | ||
Note: Cohorts were combined for all analysis. A third wave of data collection is ongoing for the 2nd female cohort.